Natus wins three-year Novation contract for neoBLUE:
This article was originally published in Clinica
Executive Summary
Natus Medical, the San Carlos, California company specialising in medical devices for the paediatric market, has secured a three-year agreement to supply Novation with its neoBLUE LED phototherapy systems, used to treat neonatal jaundice. Irving, Texas-based Novation, in turn, will distribute the devices to US healthcare alliances VHA and University HealthSystem Consortium. The neoBLUE system uses a therapeutic blue LED (light emitting diode) light to degenerate excess bilirubin in jaundiced infants. Healthcare users have said the product provides effective and safe treatment to babies over a shorter period of time, the company claims.